Cargando…
Ibuprofen, other NSAIDs and COVID-19: a narrative review
At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to manage some of the symptoms of COVID-19, could increase the susceptibility to severe acute respiratory syndrome coronavi...
Autores principales: | Laughey, William, Lodhi, Imran, Pennick, Graham, Smart, Lucinda, Sanni, Olutoba, Sandhu, Suneet, Charlesworth, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518289/ https://www.ncbi.nlm.nih.gov/pubmed/37603158 http://dx.doi.org/10.1007/s10787-023-01309-7 |
Ejemplares similares
-
A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality
por: Smart, Lucinda, et al.
Publicado: (2020) -
Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection
por: de Bruin, Natasja, et al.
Publicado: (2022) -
Cardiorenal Effects of Newer NSAIDs (Celecoxib) versus Classic NSAIDs (Ibuprofen) in Patients with Arthritis
por: Hegazy, Ragia, et al.
Publicado: (2011) -
NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X Receptor
por: Schmidt, Jurema, et al.
Publicado: (2015) -
Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study
por: Xie, Junqing, et al.
Publicado: (2023)